News

Upcoming gene therapies may be the most economical option for people with haemophilia types A and B to address their illness, even with a steep price tag of $2.5 million for each treatment. In a preliminary evidence report made...

The WHO has urged nations to invest promptly in research, recovery, and rehabilitation in order to treat the post-COVID-19 syndrome seriously. At least 17 million people in the 53 Member States of the WHO European Region may have encountered post-COVID-19...

The Biden Administration is previewing its next step in regaining American leadership in the pharmaceutical industry after focusing on the country's supply chains for pharmaceuticals last winter. On September 12th, President Joe Biden signed an executive order to advance...

The history of the medical field is a fascinating one. When the slightest thing can mean life or death in this field, looking back at how wrong the brightest minds of the world initially were makes for tense reading....

Once you discover that you or your partner has pearly penile papules, it’s easy to feel like it’s the end of the world—this feeling has its roots in the fact that you have little to no knowledge about it....

The next-generation biotherapeutics will receive $300 million from Novartis, according to the company. To build a fully integrated, dedicated scientific environment to boost its capabilities and capacity for early technological development of biologics, the multi-year investment will be deployed...

In the United States, adults and kids with monkeypox infection are now being enrolled in a Phase 3 clinical trial assessing the antiviral tecovirimat, better known as TPOXX. The study's researchers hope to include more than 500 participants from...